S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
S&P 500   3,373.23 (-0.38%)
DOW   29,219.98 (-0.44%)
QQQ   234.78 (-0.93%)
AAPL   320.30 (-1.03%)
FB   214.58 (-1.34%)
MSFT   184.42 (-1.53%)
GOOGL   1,516.99 (-0.52%)
AMZN   2,153.13 (-0.79%)
CGC   22.31 (+2.48%)
NVDA   308.70 (-1.91%)
BABA   218.04 (-1.85%)
MU   59.00 (-1.65%)
GE   12.53 (-0.63%)
TSLA   899.41 (-1.96%)
AMD   57.27 (-2.77%)
T   38.61 (+0.44%)
ACB   1.68 (-1.75%)
F   8.03 (+0.38%)
NFLX   386.00 (-0.05%)
PRI   136.40 (+0.52%)
BAC   34.85 (+0.37%)
DIS   140.37 (-0.66%)
GILD   67.00 (-0.52%)
Log in

Tonix Pharmaceuticals SEC Filings & 10K Form (NASDAQ:TNXP)

$0.45
+0.03 (+7.12 %)
(As of 02/20/2020 04:00 PM ET)
Today's Range
$0.42
Now: $0.45
$0.47
50-Day Range
$0.42
MA: $1.19
$1.70
52-Week Range
$0.41
Now: $0.45
$42.00
Volume1.29 million shs
Average Volume2.25 million shs
Market Capitalization$3.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08

SEC Filings

Tonix Pharmaceuticals (NASDAQ:TNXP) SEC Filings

DateFilerForm TypeView
02/14/2020
2:39 PM
Altium Capital Management LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
2:09 PM
ARMISTICE CAPITAL, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
9:22 AM
Iroquois Capital Management, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
8:03 AM
CVI Investments, Inc. (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
02/12/2020
1:33 PM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
02/11/2020
6:45 AM
Tonix Pharmaceuticals (Filer)
Form 424B4
02/10/2020
2:15 PM
CVI Investments, Inc. (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2020
12:59 PM
SABBY MANAGEMENT, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
02/06/2020
11:15 PM
Tonix Pharmaceuticals (Filer)
Form EFFECT
02/06/2020
4:18 PM
Tonix Pharmaceuticals (Subject)
Form FWP
02/06/2020
8:35 AM
Tonix Pharmaceuticals (Filer)
Form S-1/A
02/05/2020
4:21 PM
Tonix Pharmaceuticals (Subject)
Form FWP
02/05/2020
4:19 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
3:19 PM
Tonix Pharmaceuticals (Subject)
Form FWP
01/29/2020
3:19 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
12:03 PM
SABBY MANAGEMENT, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G/A
01/21/2020
6:12 AM
Tonix Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/16/2020
3:17 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
4:25 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
3:05 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
3:06 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
7:01 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:17 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2019
3:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
6:00 AM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
3:11 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
11/27/2019
5:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2019
2:34 PM
Altium Capital Management LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
11/22/2019
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
4:23 PM
Tonix Pharmaceuticals (Filer)
Form 424B4
11/15/2019
4:27 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
11:15 PM
Tonix Pharmaceuticals (Filer)
Form EFFECT
11/14/2019
3:51 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
8:25 AM
Tonix Pharmaceuticals (Filer)
Form S-1/A
11/08/2019
4:15 PM
Tonix Pharmaceuticals (Subject)
Form FWP
11/08/2019
4:13 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
3:32 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
6:11 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
6:04 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
12:51 PM
Tonix Pharmaceuticals (Subject)
Form FWP
11/01/2019
12:50 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
6:01 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
6:00 AM
Tonix Pharmaceuticals (Subject)
Form FWP
10/31/2019
12:11 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2019
4:11 PM
Tonix Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/16/2019
3:13 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2019
7:39 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
3:20 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2019
6:31 AM
Tonix Pharmaceuticals (Filer)
Form 424B3
09/11/2019
11:15 PM
Tonix Pharmaceuticals (Filer)
Form EFFECT
09/04/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
4:11 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:07 PM
Tonix Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
08/23/2019
4:03 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
3:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
6:51 AM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
3:11 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
4:04 PM
Tonix Pharmaceuticals (Filer)
Form POS EX
07/16/2019
4:03 PM
Tonix Pharmaceuticals (Filer)
Form 424B4
07/16/2019
7:50 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2019
11:15 PM
Tonix Pharmaceuticals (Filer)
Form EFFECT
07/15/2019
7:04 AM
Tonix Pharmaceuticals (Filer)
Form S-1/A
07/11/2019
5:32 AM
Tonix Pharmaceuticals (Filer)
Form S-1/A
07/03/2019
5:20 AM
Tonix Pharmaceuticals (Subject)
Form FWP
07/01/2019
4:23 PM
Tonix Pharmaceuticals (Filer)
Form S-1/A
06/19/2019
7:37 AM
Tonix Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/14/2019
3:34 PM
Tonix Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
3:12 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
7:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
6:51 AM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
7:05 AM
Goodman Daniel Wintner (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
7:01 AM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
7:01 AM
SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
7:00 AM
SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
7:00 AM
MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:59 AM
LANDRY DONALD W (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:59 AM
GRANGE DAVID L (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:58 AM
GRACE PATRICK P (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:31 AM
Goodman Daniel Wintner (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/08/2019
6:21 AM
OLUKOTUN ADEOYE Y (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:21 AM
Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:17 AM
Bell Margaret Smith (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:15 AM
Rhodes John B (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
3:33 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel